These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 27173192)
1. Prognostic significance of microRNA-10b overexpression in breast cancer: a meta-analysis. Wang N; Chen P; Huang LP; Wang TZ Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173192 [TBL] [Abstract][Full Text] [Related]
2. High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis. Hong L; Yang J; Han Y; Lu Q; Cao J; Syed L Gene; 2012 Oct; 507(2):135-8. PubMed ID: 22842193 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-10b expression predicts long-term survival in patients with solid tumor. Zhang Y; Wang LJ; Yang HQ; Wang R; Wu HJ J Cell Physiol; 2019 Feb; 234(2):1248-1256. PubMed ID: 30191959 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients. Parrella P; Barbano R; Pasculli B; Fontana A; Copetti M; Valori VM; Poeta ML; Perrone G; Righi D; Castelvetere M; Coco M; Balsamo T; Morritti M; Pellegrini F; Onetti-Muda A; Maiello E; Murgo R; Fazio VM Mol Cancer; 2014 Jun; 13():142. PubMed ID: 24897960 [TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological significance of microRNA-21 overexpression in breast cancer: a meta-analysis. Pan F; Mao H; Deng L; Li G; Geng P Int J Clin Exp Pathol; 2014; 7(9):5622-33. PubMed ID: 25337203 [TBL] [Abstract][Full Text] [Related]
6. Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis. Wang Y; Zhang Y; Pan C; Ma F; Zhang S PLoS One; 2015; 10(2):e0118647. PubMed ID: 25706383 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-10b and minichromosome maintenance complex component 5 gene as prognostic biomarkers in breast cancer. Eissa S; Matboli M; Shehata HH; Essawy NO Tumour Biol; 2015 Jun; 36(6):4487-94. PubMed ID: 25596707 [TBL] [Abstract][Full Text] [Related]
8. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients. Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells. Nishida N; Yamashita S; Mimori K; Sudo T; Tanaka F; Shibata K; Yamamoto H; Ishii H; Doki Y; Mori M Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of MiR-21 and MiR-10b Expression of Human Breast Cancer in West Sumatera. Yanwirasti ; A Harahap W; Arisanty D Pak J Biol Sci; 2017; 20(4):189-196. PubMed ID: 29023075 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-10b and the clinical outcomes of various cancers: A systematic review and meta-analysis. Huang Q; Song Q; Zhong W; Chen Y; Liang L Clin Chim Acta; 2017 Nov; 474():14-22. PubMed ID: 28864233 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and biological significance of microRNA-221 in breast cancer. Eissa S; Matboli M; Sharawy A; El-Sharkawi F Gene; 2015 Dec; 574(1):163-7. PubMed ID: 26253160 [TBL] [Abstract][Full Text] [Related]
13. Serum overexpression of microRNA-10b in patients with bone metastatic primary breast cancer. Zhao FL; Hu GD; Wang XF; Zhang XH; Zhang YK; Yu ZS J Int Med Res; 2012; 40(3):859-66. PubMed ID: 22906258 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of microRNA-375 downregulation in solid tumors: a meta-analysis. Shao Y; Geng Y; Gu W; Huang J; Ning Z; Pei H Dis Markers; 2014; 2014():626185. PubMed ID: 25404787 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-10b expression in breast cancer and its clinical association. Zhang J; Yang J; Zhang X; Xu J; Sun Y; Zhang P PLoS One; 2018; 13(2):e0192509. PubMed ID: 29408861 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of microRNA-221/222 expression in cancers: evidence from 1,204 subjects. Wang J; Liu S; Sun GP; Wang F; Zou YF; Jiao Y; Ning J; Xu J Int J Biol Markers; 2014 Jun; 29(2):e129-41. PubMed ID: 24474451 [TBL] [Abstract][Full Text] [Related]
17. miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non Triple Negative Breast Cancer: Potential Biomarkers. Fkih M'hamed I; Privat M; Trimeche M; Penault-Llorca F; Bignon YJ; Kenani A Pathol Oncol Res; 2017 Oct; 23(4):815-827. PubMed ID: 28101798 [TBL] [Abstract][Full Text] [Related]
18. High expression levels of miR-21 and miR-210 predict unfavorable survival in breast cancer: a systemic review and meta-analysis. Tang Y; Zhou X; Ji J; Chen L; Cao J; Luo J; Zhang S Int J Biol Markers; 2015 Nov; 30(4):e347-58. PubMed ID: 26349663 [TBL] [Abstract][Full Text] [Related]
19. Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients. Ota D; Mimori K; Yokobori T; Iwatsuki M; Kataoka A; Masuda N; Ishii H; Ohno S; Mori M Int J Oncol; 2011 Apr; 38(4):955-62. PubMed ID: 21271219 [TBL] [Abstract][Full Text] [Related]
20. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer. Dong LL; Chen LM; Wang WM; Zhang LM Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]